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age of 75.3 (6.0) years. The enrolment rate was 28% (out of n=1296 patients screened). The refusal to participate rate was 43%.
Study design
This was a randomized controlled trial, carried out in two centres. The duration of follow-up was 24 weeks after index hospital discharge. The attrition rate for the whole study was 28%. The intervention group had an attrition rate (including deaths) of 30% (53/177) versus 26% (48/186) in the control group, (p=0.26). The withdrawal rate because of "changed minds about participation" was 13% in the control group versus 18% in the intervention group, (p=0.28). The patients who completed the study were comparable to the attrition group in terms of sociodemographic factors and severity of illness measures. Research assistants (RAs) blinded to study groups and hypotheses collected the outcome data.
Analysis of effectiveness
The analysis of effectiveness was based on intention to treat. The primary health outcome adopted in the study was time to first readmission for any reason. Some of the other outcomes (secondary outcomes) assessed in the study were the readmission rate (at least once), multiple readmissions, hospital days per patient, post-discharge acute care visits, functional status (measured by the Enforced Social Dependancy Scale), depression (measured by the Center for Epidemiologic Studies Depression Scale), and patient satisfaction (measured by an investigator-developed instrument). The study groups were comparable in terms of sociodemographic and baseline health features. The proportional hazards regression was used to adjust for the effects of potentially confounding factors including variables such as number of prior hospitalisations within the past 6 months, and living with relative or friends rather than with spouse.
Effectiveness results
The intervention group had a significantly longer time to first readmission for any reason (log-rank chi-square=1.1, p<0.001); and this premise remained true even after adjusting for simultaneously significant confounding variables. When the control group was compared with the intervention group, the crude rate of relative readmission was 1.96 (95% CI: 1.31 -2.92). When adjusted, the rate was 2.03 (95% CI: 1.34 -3.08). The readmission rate (at least once) was 37.1% in the control group versus 20.3% in the intervention group, (p<0.001). The multiple readmission rate was 14.5% versus 6.2%, (p=0.01), respectively. The hospital days per patient were 4.09 days (control) versus 1.53 (intervention), (p<0.001). The study showed no significant differences between the groups in terms of post-discharge acute care visits, functional status, depression, and patient satisfaction.
Clinical conclusions
The authors believe that the focus of the clinical intervention on the combined effects of primary health problems, comorbid conditions, and other health and social issues common in this patient population, rather than on the management of a single disease, was a major factor in its success.
Measure of benefits used in the economic analysis
No summary benefit measure was identified in the economic analysis, and only separate clinical outcomes were reported.
Direct costs
Costs were not required to be discounted due to the short follow-up period of the study. Quantities of resources used were reported separately from the costs. Cost items were reported separately. The cost analysis covered the costs of acute care visits, home visits, therapists, social workers, and home health aides. The perspective adopted in the cost analysis was that of Medicare. Charges and actual Medicare reimbursements were used as proxies for true costs. Detailed logs were used to assess APN intervention-related effort after discharge, which was multiplied in Medicare reimbursement rates (the same rate as that applied for visiting nurses (VN)) to calculate the costs associated with the APN services after discharge. The date of the price data was not explicitly specified. It was reported that the cost
